⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN Investor Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
globenewswire.com
REGN
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg
businesswire.com
REGN
Pomerantz LLP Calls Attention to Class Action Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
REGN Class Action Notice: Regeneron Hit with Securities Fraud Lawsuit over Trial Misrepresentations – Investors Urged to Contact BFA Law by September 14 Deadline
globenewswire.com
REGN
Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN
prnewswire.com
REGN
September 14, 2026 Deadline Approaching: Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky
accessnewswire.com
REGN